#IDMed
LightNews LightNews
ichs-global.bsky.social
#IDMed
November 18, 2024 at 8:39 PM
bnuyflops.bsky.social
IDMED YIU
February 22, 2026 at 11:28 PM
guerreroespejo.bsky.social
A polymerase-chain-reaction: Mycobacterium leprae.

The development of severe, necrotizing, cutaneous lesions in patients with diffuse lepromatous #leprosy, known as LUCIO’S PHENOMENON, is uncommon.
3/3

#IDMed #ClinicalCase #InfectiousDiseases #ClinicalMicrobiology
May 31, 2026 at 6:01 AM
springermedicine.com
In the latest episode of Medicine Matters, Dr. Hamish Mohammed discusses the rollout of the world’s first vaccination program against #gonorrhea.

Listen to the full episode now 👉 buff.ly/f43d15Z

#STIs #IDMed #MedSky
August 25, 2025 at 3:15 PM
contagionlive.bsky.social
Colleen Kelley MD, MPH, offers some insights on where we are today with the state of HIV prevention including the expanding PrEP options, why PEP is underutilized, and the challenges behind HIV vaccine development. #CROI #croi2025
#IDsky #IDMed
HIV Prevention: Discussing PrEP, PEP, and Vaccine Development
Colleen Kelley, MD, MPH, offers some insights on where we are today with the state of HIV prevention including the expanding PrEP options, why PEP is underutilized, and the challenges behind HIV vacci...
www.contagionlive.com
March 13, 2025 at 5:22 PM
springermedicine.com
#Burkholderia species present substantial diagnostic and therapeutic challenges due to their virulence and intrinsic antimicrobial resistance.

This review synthesizes current knowledge on the clinically significant pathogens.

👉 buff.ly/pkTf3ui

#IDMed #Melioidosis
Human infections caused by pathogenic Burkholderia: current clinical challenges and future perspectives
Burkholderia species present substantial diagnostic and therapeutic challenges due to their virulence and intrinsic antimicrobial resistance. This review synthesizes current knowledge on the…
springermedicine.com
March 2, 2026 at 4:15 PM
springermedicine.com
From #ESCCongress 2026: Among individuals with left-sided infective endocarditis participating in the POET II trial, a response-tailored antibiotic strategy reduced treatment duration by 2 weeks.

👉️ buff.ly/hnd8aUv

#IDMed #CardioSky
Tailored approach could shorten antibiotics duration in infective endocarditis
Among individuals with left-sided infective endocarditis participating in the POET II trial, a response-tailored antibiotic strategy reduced treatment duration by 2 weeks.
www.springermedicine.com
September 6, 2026 at 8:01 AM
springermedicine.com
Discover the infection risk profiles of the 15 antibody–drug conjugates that are currently approved, and understand the pathophysiological mechanisms, antigen-specific clinical patterns, and evidence-based prophylaxis strategies

👉️ buff.ly/MZkYjMr

#OncSky #IDMed
Infectious Complications of Antibody–Drug Conjugates: A Review of Safety Data from FDA-Approved Agents
Review the infection risk profiles of the 15 antibody–drug conjugates that are currently approved, and understand the pathophysiological mechanisms, antigen-specific clinical patterns, and…
www.springermedicine.com
July 29, 2026 at 6:25 PM
anthonyolszewski.bsky.social
#Influenza #PublicHealth #IdSky #IDPed #IDMed #Medicine #InfectiousDisease
cidrap.bsky.social CIDRAP @cidrap.bsky.social · Jan 7
Boston reports first pediatric flu deaths since 2013 as flu illness surges across US

Nationwide, the CDC said 5,000 people have died so far this season.

www.cidrap.umn.edu/i...
January 9, 2026 at 3:44 AM
anthonyolszewski.bsky.social
#PublicHealth #IDSky #IDMed #infectiousDisease #Medicine
January 5, 2026 at 4:07 PM
epsteinweb.bsky.social
Parts 1-3/3 — EFTA01708660.jpg
#epsteinweb #efta01708660
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
EFTA01708650 | EFTA01708660 Pege A Peco A SVCS UNLIMITEO Account name Accpmt number Statement dote BII0ng period C Ctrč3ÇMINF SVCS UNLIMITED Account name Account nbmber Statement dale Bining period March 11 - Apr410, 2004 ~ D4 March 11 - April 10,2004 C ~onOhued... con0nıed... - Telecommunlcations ServlcesCall Detail Tekcommunicalions Services Celi Detajl Time Call To Nun bor FOOtlıte $00 Long 5ee ıtemlDatO L MIn:Seı U»g0 Dlstance G11To IDMeD»Q TUIo NumbM Feomete Mıı:50e UiagO Long T<Ot1 Dlstanee Char0o5 444 wr 22 1č:č0 ıw Y MIN 0N.rt. M č:a 0.00 0.0< Tat wr » M:>l MI 1ns01m Pr ı:0> 0.0> 0.00 66> Mar Si 11.30 M 1Kwı1oa M a:p 0.60 0.04 Tai Kat » 0>.F0 >N YmNm PP 1:00 0.01 0.00 644 Wr 22 1i:r1 M IKMiM PP <:00 O.M 0.C< Tit IYr 5) 10:00 HI IOmniM PP l:M 0.01 0.00 0:5č PC aa t.p 0.00 TH Kar a) >0:00 Nı HmatM M ı,M 0.m 0.00 684 nıe >a 00.08 M WPN:MI.1L PP a:M 0.04 0.C< Tag MM 2> IO,H NI LO.MM PP l,M 0.01 0.00 aM 14r 22 01:č0 M M r.Wl NN.PL M tıp O.N 0A< »1 Me l) 101č> H1 SmmO) PP 4:00 0.01 0.00 re 1100 0.44 0.04 M <.a0 e.m 0.00 601 Mr 22 0L5v M Ia<>.LLn> M a,M 0.00 0.04 P.M T>i IYr » 402 wr ıa 0>:5> 14414 MIM MI.1S >'r ı:M t.w 0.00 0.m iH Kal a> 31,22 M N.m.Oq Ml wr 22 0>.r< snemo ON.1r. tl l.M 0.04 0.ee 0.00 TT51Yr » IamKM tel Y P.WI 000.07. PP 4,44 0.0< C.W iı er 1.00 0.M 0.0< 4.40 TY>ur H Wč Mar n eM rac » M le<wuM 0rer M čııcNe/ 644 Mar aa 0t:ii 6M Nar aı 0mP M >r<Wq 4.00 T>1 W 83 H,PI>N L~lq 11100 NI Y Nin MI.PL Pr l:M 0.00 M >,a 0.00 M M l.a 0.00 Y<r 11 01.05 M >cW>.lM Pl.0P M la<ONnP M >.M 0>.oi M 5.0> 0.<0 0.00 0.0> 600 wr 22 08.43 M Y aVN 000.10. 0P f:p 0.05 0.0< 0.00 TTS We l) On.0) M Y hVM P(N.PL M l,M 0.<0 0.02 0.0Y GO? Par » 0>.05 M V P1111 On.M. tr •.M 0.00 0.04 O .0> 730114. a) OIIPl M Y INY. MI.PL PP 1,00 0.00 0.03 0.00 M11Mr ič 0f,M M V MYII 004.10. re i:M O.Or 0.04 4.00 Ib Kar a) Pt,tP M LmNM M <.M 0.<0 0.m Mo rıe 22 M:51 11414 IODI sea.R t0 >:M 0.00 0.01 T<i MV T) M.H M LmNM PP s,00 0.e0 700 Me ča očıač M Y M41 0<8.M1 M 5:M 0.00 o.0t 15,M 0.04 0.0> 0.M PP 5.00 0.M 0.0f I6I oso a> M.PI M Ymn1M T6>grT>N>HMYpVMNN.r. 10/004 701 rar a> 0>,ır M Y 6NM 0014.17. OP <,00 0.44 0.% 0.00 702 Mar čč 0).15 M Y bW1 MLR PO 1:00 0.0> TM nor a) 44,44 M H<Wy 0e/<*' •,m 0.40 0.0> 0.00 >0> rar 22 W:5< tel >%r+1:y 00 ):00 0.00 0.08 HOOYe Pl M.<0 M Y DVII >d.r 00 ),m 0.40 0.0> 0.00 11111 PaIM W1.rL M 1,00 0.00 O.00 TM M4' T) M.OI M H<enınl YI l,M 0.00 0.01 0.00 e6:M M Y oaL: OG.OL M č.0a 0.00 1.00 Ta Vara) M>P) M HmOlnT PC >,00 o.M 0.0> 0.M 22 00:0) M rrG•.COC6.1L M i,00 0.00 0.00 0.00 Tw1Yr» P> ı:00 0.1.0 0.0> O.Oo M <:00 0.00 O.M T6TMM» 0)9) M l>mNnT PP •,00 0.0> 0.<0 M iir0 <.0C 0.00 Tb IYr a) 0<nl M >Omnlm rt >.00 0.0> 0.00 M 2,00 0.00 0.00 751 IYr )) M>T5 M Y P.VM aQ.PL rt 1:00 0.0> 0.00 510 Kar 1> O<:a0 M V Pa1M OfJ.R M 1ı00 0.00 0.00 782 Kar )> Mm ve >,o0 0.m 0.00 O.re 704 Var 22 MS Var » 700 4r i0l 1W aa 01:N M i0a>ahp 3M>V aa a.1a M ı0mlro čb0wr»M.><M300 1aı,g 0.00 OT,55 M Y Me. Kıl.PL M Y MiN q,». 0.<0 0.40 M:al M'Y MJN O6.rL M 5:00 0.00 0.00 753 Mar >) 01.74 M Lmin) PO 2,30 0.00 0.00 712 var ač 16:15 11414 PNM Bni.ry M 0:00 0.00 0.00 0.00 TN Mar 5> 0454 M Tnmr>N PP >:M 0.00 0.0> 0.<0 7111405 T> 0<.15 M ><m01 j M/a 1,00 0.00 0.00 0.40 Trb PP 1.00 0.00 0.0> 0.<0 >111Yr » Mat a) 00.44 M Oıa~lro 714 Mr » K.5< M 70000105 ir 11:c0 0.00 0.00 0.00 Tb Mrr A Il NM 0.M 0.0> 0.<0 T10 Mar » M:00 M ]6<a01r0 r0 čL<0 0.00 0.00 0.00 767 Kar a) »IM M P IyM PR.PL 1P 1,M a.M 0.0> 0.00 >10 Mv aa M.00 M v DIN M.rL Il 2.40 0.00 0.00 Tv Kara) 10 >.M 0.40 0.07 0.00 717 Mae » M 1:<0 C.00 0.00 0.00 T30 Mr a) 07.61 M Y M11M 800.17. PP a.M 0.00 0.02 0.00 M:<P AM V la1M 001.17. 0TO1 M L6>O>N n.ı0 M Y M1M q.rt T101Ye T) M:<0 M Y PaNI 000.17. af lito 0.00 0.00 T(0 Mr a) 001M M Y Mal< Kl.rl. It l,M 0.0 0.0> 0.<0 710 ras aı M.lı Ca 4.00 0.00 0.01 781 Kar T> 0)184 M Y MM K1.PL 00 a,m O.M 0.0> 0.<0 ce >.ro 0.00 0.0e 0.40 782 Mr H M.0 LmalnT oP •.M 0.00 0.0> 0.<0 Il 1ı00 0.00 0.•0 703 Yae H 0T,H M Y MVI OP.IL IP >.m 0.40 0.01 0.e0 AM >aCMb:> 720 Me » M.f1 M Y MN1 On.n ı> Mar ar 0>u0 N> »aOlro T)č Kir » 01.ır N0 v rYN qı.M. 723 Kar » a.ıT TN Sar a) Mı» PP 0.<0 0.00 0.00 0.00 :01 Me 56 Mm M v 1rJM 001.17. Il 0.00 0.00 0.00 0.00 768 Mr H M MM>.r r< 5.<e e.oı o.aa » 5.00 e.ıı 0.00 ča1 Mr 2) M.M M č6oW60 M M.51 M Ht Mar aı nm 0.40 M M 287 Nar 50 00>ts M >nmNM PP >,00 0.00 0.0> 0.00 Y PNM 001.12. PP >,M 0.40 0.0> 0.00 Iemnl,y ve 1.0o e.M 0.0> 0.00 P Muı On.eL » >,00 0.40 0.0> 0.00 EFTA01708660 Epstein Web iOS app on the App Store.
March 7, 2026 at 3:17 PM
springermedicine.com
Antimicrobial agents treating bone and joint infections require reliable bone penetration, an appropriate spectrum, and favorable tolerability.

Review the pharmacology and clinical efficacy of #tetracyclines in the context of BJIs.

👉 buff.ly/Mchh2U2

#IDMed #OrthoSky
Efficacy and Safety of Tetracyclines in Bone and Joint Infections: A Literature Review
Antimicrobial agents treating bone and joint infections require reliable bone penetration, an appropriate spectrum, and favourable tolerability. Review the pharmacology and clinical efficacy of…
springermedicine.com
April 20, 2026 at 1:49 PM
springermedicine.com
#MedCase - An immunocompetent patient developed rapidly progressive #NecrotizingFasciitis of the scrotum and right thigh following minor cycling abrasions.

Subsequent #SepticShock and multi-organ failure required urgent multidisciplinary collaboration.

👉 buff.ly/8b2B7PS

#IDMed
Case report: Necrotizing fasciitis involving the bilateral scrotum and right leg caused by Streptococcus pyogenes in a healthy male: a multidisciplinary diagnostic and therapeutic analysis
An immunocompetent patient developed rapidly progressive necrotizing fasciitis of the scrotum and right thigh following minor cycling abrasions. Subsequent septic shock and multi-organ failure…
springermedicine.com
April 8, 2026 at 10:54 AM
springermedicine.com
Explore current imaging, serological, and immunological techniques for identifying hydatid cysts in cystic echinococcosis as well as the recent breakthroughs in recombinant antigen-based assays and nanobiosensors.

👉 buff.ly/tu6UOIM

#IDMed
Recent advances in clinical and laboratory diagnosis of hydatid cyst: from imaging to recombinant and nanobiosensor-based approaches
Explore current imaging, serological, and immunological techniques for identifying hydatid cysts in cystic echinococcosis as well as the recent breakthroughs in recombinant antigen-based assays and…
www.springermedicine.com
March 24, 2026 at 9:01 AM
springermedicine.com
#MedNews - Albumin replacement in #SepticShock does not improve 90-day survival compared with standard fluid resuscitation, the ARISS trial shows.

Full story 👉 buff.ly/Vfrl5FY

#IDMed #ICUMed
No 90-day survival benefit with albumin in septic shock patients
Albumin replacement in septic shock does not improve 90-day survival compared with standard fluid resuscitation, the ARISS trial shows.
springermedicine.com
March 4, 2026 at 11:54 AM
springermedicine.com
#MedNews - An oral whole-cell vaccine against enterotoxigenic #EColi is immunogenic and well tolerated in infants, and should advance to a phase 3 trial.

👉 buff.ly/72hPj2b

#IDMed #GastroSky
ETVAX protects against infant enterotoxigenic E. coli diarrhea
An oral whole-cell vaccine against enterotoxigenic Escherichia coli is immunogenic and well tolerated in infants, and should advance to a phase 3 trial.
buff.ly
February 28, 2026 at 11:54 AM
springermedicine.com
#MedNews - Approximately 10% of disorders of gut–brain interaction may be triggered by acute infectious #gastroenteritis, with rates varying globally and by sociodemographic factors.

Full story 👉 buff.ly/SFiqKb6

#GastroSky #IDMed
Acute infectious gastroenteritis common trigger of long-term gastrointestinal disorders
Approximately 10% of disorders of gut–brain interaction may be triggered by acute infectious gastroenteritis, with rates varying globally and by sociodemographic factors.
buff.ly
February 11, 2026 at 7:25 PM
springermedicine.com
#MedNews - #HPV testing of self-collected menstrual blood is as effective as conventional cervical screening for the detection of grade 2 or higher cervical intraepithelial neoplasia.

Full story 👉 buff.ly/0btALbr

#OncSky #IDMed
Menstrual blood eases HPV screening for cervical cancer
HPV testing of self-collected menstrual blood is as effective as conventional cervical screening for the detection of grade 2 or higher cervical intraepithelial neoplasia.
buff.ly
February 11, 2026 at 4:22 PM
springermedicine.com
From #ESCMID2025 - Interleukin-6 shows promise as a biomarker to diagnose #sepsis early in high-risk patient groups such as neonates, children, and pregnant women.

Full story 👉 buff.ly/RQwK5v9

#IDMed #PediatricMed
IL-6 shows promise as diagnostic biomarker for sepsis in high-risk populations
Interleukin-6 shows promise as a biomarker to diagnose sepsis early in high-risk patient groups such as neonates, children, and pregnant women.
www.springermedicine.com
January 20, 2026 at 9:01 AM
springermedicine.com
Clinical #biofilms significantly contribute to healthcare-associated infections.

Conventional antibiotic therapies often face challenges against biofilm-associated infections, but these novel interventions show promise.

👉 buff.ly/7eoNm9S

#IDMed #MedSky
Regulation and Therapeutic Intervention of Bacterial Biofilms
Clinical biofilms are complex, polymicrobial communities that significantly contribute to healthcare-associated infections. Conventional antibiotic therapies often face challenges against…
buff.ly
December 23, 2025 at 9:00 AM
springermedicine.com
Effective management of #scabies in older adults can be difficult, particularly in institutional and resource-limited settings.

How can these challenges be overcome, especially when faced with an institutional outbreak?

👉 buff.ly/UZMPUcq

#GeriatricCare #IDMed
Scabies in older adults: What Is New in Diagnosis and Treatment?
Effective diagnosis and treatment of scabies in older adults can be difficult, particularly in institutional and resource-limited settings. How can these challenges be overcome, especially when faced…
www.springermedicine.com
June 26, 2025 at 3:15 PM
ffgster.bsky.social
iDMed.nl
Home | iDMed
IDMed.nl
December 1, 2024 at 8:58 PM